Honeywell Signs Definitive Agreement to Acquire Norcross Safety Products, Innovator of Highly Engineered and Patented Personal Protective Gear

Health & safety

Honeywell Signs Definitive Agreement to Acquire Norcross Safety Products, Innovator of Highly Engineered and Patented Personal Protective Gear

13 Jun, 2008

Published over 18 years ago. See the latest and most current information on Health & safety.

Honeywell (USA) today announced a definitive agreement to acquire Norcross Safety Products L.L.C., a leading manufacturer of Personal Protective Equipment (PPE), for approximately $1.2 billion.
Norcross manufactures a wide range of protective and safety equipment for the fire service, utility and general industrial worker segments. The agreement is subject to customary closing conditions, including regulatory review. Norcross will be integrated into Honeywell Life Safety, part of Honeywell's Automation and Control Solutions (ACS) group. Norcross's revenue was approximately $609 million in 2007.
"From emergency responders, to electrical workers to the industrial workforce, Norcross's innovative solutions protect those who work in
environments where safety protection is paramount," said Roger Fradin, President and CEO of Honeywell ACS. "With more than 100 years of industry experience, best-in-class solutions and trusted brands, and a strong management team with exceptional talent and depth, Norcross is a globally recognized industry leader that will bolster our offerings to our customers in key Life Safety segments."

Latest News

IET Guide 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Portable fluorescence reader could bring forward molecular tests for use at home
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Vietnam’s E10 rollout puts fuel testing capacity under closer scrutiny
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow